Raltegravir T2239L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Raltegravir is a pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION.
CAS nr:
518048-05-0
Purity:
98%
Molecular Weight:
444,42
SMILES:
Cc1nnc(o1)C(=O)NC(C)(C)c1nc(c(c(=O)n1C)O)C(=O)NCc1ccc(cc1)F
Formula:
C20H21FN6O5
Pathway:
Microbiology/Virology,Proteases/Proteasome,Microbiology/Virology
Target:
Integrase,HIV Protease,HIV Protease
